+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID05904665

Postoperative Follow-up Using Circulating Tumor DNA Methylation Monitoring for Non-metastatic Colorectal Cancer A Multicenter, Randomized Controlled Cohort Study

Led by Fudan University · Updated on 2025-09-18

584

Participants Needed

1

Research Sites

150 weeks

Total Duration

AI-Summary

What This Trial Is About

Colorectal cancer CRC is a common and serious gastrointestinal tumor with high incidence and mortality rates worldwide. While early-stage CRC patients have a high survival rate, those with high-risk stage II and III CRC face lower survival and frequent recurrence after surgery. Researchers are evaluating the use of circulating tumor DNA ctDNA methylation detection as a more sensitive biomarker to predict and monitor postoperative recurrence and metastasis in non-metastatic CRC patients, aiming to improve follow-up strategies. The study compares two groups one receiving dynamic ctDNA methylation monitoring alongside routine postoperative follow-up, and the other receiving only routine follow-up care. ctDNA testing is performed before surgery, shortly after surgery, and every three months for two years in the experimental group. If ctDNA testing indicates positive results after chemotherapy, additional imaging is conducted to detect recurrence or metastasis. Routine follow-up includes physical exams, blood tests for carcinoembryonic antigen CEA, CT scans, and colonoscopies at scheduled intervals. Participants will undergo regular blood tests for ctDNA, physical exams, imaging scans, and questionnaires on quality of life and emotional distress for up to five years. Researchers will measure outcomes such as the rate of secondary curative treatment, time to cancer recurrence, disease-free survival, overall survival, and patient-reported outcomes. This study provides close monitoring and aims to identify recurrence earlier through ctDNA changes, potentially guiding more timely interventions.

CONDITIONS

Brief Title

Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for Non-metastatic Colorectal Cancer

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here